Efficacy (and safety) of vaccination against SARS-CoV-2 in cancer patients on active treatment
Since the COVID-19 pandemic, cancer patients have been recognized as a group with an increased risk of complications, if they become infected with the SARS-CoV-2 virus. However, they were not included in registrational trials for COVID-19 vaccines. In the last few months data from studies investiga...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | SL |
| Publicado: |
Institute of Oncology Ljubljana
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/88e12c42dff240bfa773b79412dac2c8 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|